Prosight Management’s Insmed INSM Stock Holding History

Prosight Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-26,359	Closed	-$449K	–	42
2023 Q1	$449K	Buy	+26,359	New	+$512K	0.21%	34

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prosight Management's INSM Position: Q2 2023 in Review

Prosight Management sold out of Insmed (INSM) in Q2 2023, closing a stake of 26,359 shares — an estimated $449K sold.

Prosight Management first reported a position in INSM in Q1 2023 and held it in 1 quarter. The position peaked at $449K in Q1 2023. 223 funds tracked by Wall St. Rank hold INSM as of Q2 2023.

Prosight Management reported no remaining Insmed position as of Q2 2023 after selling out during the quarter.
Prosight Management sold 26,359 Insmed shares in Q2 2023, an estimated $449K.
Prosight Management first reported a position in Insmed in Q1 2023 and held it in 1 quarter.
Prosight Management's Insmed position peaked at $449K in Q1 2023.
223 funds tracked by Wall St. Rank held Insmed as of Q2 2023.

Based on Prosight Management's 13F filing for Q2 2023, filed 14 Aug 2023.